{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:44:06Z","timestamp":1792453446448,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07518-w","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:37:22Z","timestamp":1792453042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carbapenem  resistance and mortality in pediatric Acinetobacter bloodstream infections: determinants from a 12-year tertiary-care cohort study"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2160-0251","authenticated-orcid":false,"given":"Suleyman Emre","family":"Karauzum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-0892","authenticated-orcid":false,"given":"Ece","family":"Erci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-9501","authenticated-orcid":false,"given":"Gulizar","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1209-2534","authenticated-orcid":false,"given":"Pinar","family":"Yazici Ozkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5842-0292","authenticated-orcid":false,"given":"Ezgi","family":"Kiran Tasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6533-6256","authenticated-orcid":false,"given":"Miray","family":"Karakoyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7111-4214","authenticated-orcid":false,"given":"Gulcihan","family":"Ozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3419-5814","authenticated-orcid":false,"given":"Eda","family":"Ataseven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0970-6582","authenticated-orcid":false,"given":"Demet","family":"Terek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-2314","authenticated-orcid":false,"given":"Melike","family":"Yasar Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3993-3396","authenticated-orcid":false,"given":"Fatma Feriha","family":"Cilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9189-8220","authenticated-orcid":false,"given":"Zumrut","family":"Sahbudak Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0562-3544","authenticated-orcid":false,"given":"Gulhadiye","family":"Avcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"7518_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"7518_CR2","volume-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization, Geneva"},{"key":"7518_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14060557","volume":"14","author":"ME Falagas","year":"2025","unstructured":"Falagas ME, Kontogiannis DS, Zidrou M, Filippou C, Tansarli GS (2025) Global epidemiology and antimicrobial resistance of metallo-\u03b2-lactamase (MBL)-producing Acinetobacter clinical isolates: a systematic review. Pathogens 14:557. https:\/\/doi.org\/10.3390\/pathogens14060557","journal-title":"Pathogens"},{"key":"7518_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14144928","volume":"14","author":"E Truszkowska","year":"2025","unstructured":"Truszkowska E, Czy\u017cewski K, Derwich K et al (2025) Clinical analysis of Acinetobacter species infections in children and adolescents treated for cancer or undergoing hematopoietic cell transplantation: a multicenter nationwide study. J Clin Med 14:4928. https:\/\/doi.org\/10.3390\/jcm14144928","journal-title":"J Clin Med"},{"key":"7518_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/2049-632X.12125","volume":"71","author":"LCS Antunes","year":"2014","unstructured":"Antunes LCS, Visca P, Towner KJ (2014) Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71:292\u2013301. https:\/\/doi.org\/10.1111\/2049-632X.12125","journal-title":"Pathog Dis"},{"key":"7518_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf134","volume":"7","author":"A Boutzoukas","year":"2025","unstructured":"Boutzoukas A, Doi Y (2025) The global epidemiology of carbapenem-resistant Acinetobacter baumannii. JAC Antimicrob Resist 7:dlaf134. https:\/\/doi.org\/10.1093\/jacamr\/dlaf134","journal-title":"JAC Antimicrob Resist"},{"key":"7518_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1695-8","volume":"16","author":"ACQ Le\u00e3o","year":"2016","unstructured":"Le\u00e3o ACQ, Menezes PR, Oliveira MS, Levin AS (2016) Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis. BMC Infect Dis 16:386. https:\/\/doi.org\/10.1186\/s12879-016-1695-8","journal-title":"BMC Infect Dis"},{"key":"7518_CR8","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.ajic.2013.01.006","volume":"41","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Wan Y, Zhou L, Ye M, Liu S, Xu C, He Y, Chen J (2013) Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. Am J Infect Control 41:e59\u2013e63. https:\/\/doi.org\/10.1016\/j.ajic.2013.01.006","journal-title":"Am J Infect Control"},{"key":"7518_CR9","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.18295\/squmj.2018.18.01.012","volume":"18","author":"AM Sultan","year":"2018","unstructured":"Sultan AM, Seliem WA (2018) Identifying risk factors for healthcare-associated infections caused by carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Sultan Qaboos Univ Med J 18:e75\u2013e80. https:\/\/doi.org\/10.18295\/squmj.2018.18.01.012","journal-title":"Sultan Qaboos Univ Med J"},{"key":"7518_CR10","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001735","volume":"25","author":"F L\u00f6tsch","year":"2020","unstructured":"L\u00f6tsch F, Albiger B, Monnet DL et al (2020) Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Euro Surveill 25:2001735. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.45.2001735","journal-title":"Euro Surveill"},{"key":"7518_CR11","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:82532","volume-title":"Antibiotic resistance threats in the United States, 2019","author":"Centers for Disease Control and Prevention (U.S.)","year":"2019","unstructured":"Centers for Disease Control and Prevention (U.S.) (2019) Antibiotic resistance threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.)"},{"key":"7518_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01063-24","volume":"69","author":"CJ Kubin","year":"2025","unstructured":"Kubin CJ, Garzia C, Uhlemann A-C (2025) Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations. Antimicrob Agents Chemother 69:e0106324. https:\/\/doi.org\/10.1128\/aac.01063-24","journal-title":"Antimicrob Agents Chemother"},{"key":"7518_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05321-y","volume":"20","author":"J Shi","year":"2020","unstructured":"Shi J, Sun T, Cui Y, Wang C, Wang F, Zhou Y, Miao H, Shan Y, Zhang Y (2020) Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit. BMC Infect Dis 20:597. https:\/\/doi.org\/10.1186\/s12879-020-05321-y","journal-title":"BMC Infect Dis"},{"key":"7518_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1282413","volume":"11","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu G, Miao F, Huang W, Wang H, Wang X (2023) Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children. Front Public Health 11:1282413. https:\/\/doi.org\/10.3389\/fpubh.2023.1282413","journal-title":"Front Public Health"},{"key":"7518_CR15","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1089\/mdr.2018.0465","volume":"25","author":"YJ Choe","year":"2019","unstructured":"Choe YJ, Lee HJ, Choi EH (2019) Risk factors for mortality in children with Acinetobacter baumannii bacteremia in South Korea: the role of carbapenem resistance. Microb Drug Resist 25:1210\u20131218. https:\/\/doi.org\/10.1089\/mdr.2018.0465","journal-title":"Microb Drug Resist"},{"key":"7518_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116324","volume":"109","author":"DD Gumus","year":"2024","unstructured":"Gumus DD, Demir OO, Aykac K, Hazirolan G, Avci H, Ceyhan M, Cengiz AB, Ozsurekci Y (2024) Gram-negative bacteremia, the risk factors, and outcome in children. Diagn Microbiol Infect Dis 109:116324. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116324","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7518_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/jpids\/piad046","volume":"12","author":"JI Castillo Bejarano","year":"2023","unstructured":"Castillo Bejarano JI, Llaca D\u00edaz J, E la O Cavazos ME, S\u00e1nchez Alan\u00eds H, Mascare\u00f1as de Los Santos AH, Espinosa-Villase\u00f1or F, Aguayo Samaniego R, Siller Rodr\u00edguez D, Casillas Vega N (2023) Carbapenem-resistant Acinetobacter baumannii infection in children from a third-level hospital in Mexico: clinical characteristics and molecular epidemiology. J Pediatric Infect Dis Soc 12:431\u2013435. https:\/\/doi.org\/10.1093\/jpids\/piad046","journal-title":"J Pediatric Infect Dis Soc"},{"key":"7518_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.100989","volume":"6","author":"S Meiring","year":"2025","unstructured":"Meiring S, Quan V, Mashau R et al (2025) Pathogen aetiology and risk factors for death among neonates with bloodstream infections at lower-tier South African hospitals: a cross-sectional study. Lancet Microbe 6:100989. https:\/\/doi.org\/10.1016\/j.lanmic.2024.100989","journal-title":"Lancet Microbe"},{"key":"7518_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08789-6","volume":"23","author":"J Li","year":"2023","unstructured":"Li J, Feng X, Wang J et al (2023) Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study. BMC Infect Dis 23:796. https:\/\/doi.org\/10.1186\/s12879-023-08789-6","journal-title":"BMC Infect Dis"},{"key":"7518_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jiac.2020.12.024","volume":"27","author":"G Guner Ozenen","year":"2021","unstructured":"Guner Ozenen G, Sahbudak Bal Z, Umit Z, Avcu G, Tekin D, Kurugol Z, Cilli F, Ozkinay F (2021) Nosocomial non-fermentative gram negative bacteria bloodstream infections in children; risk factors and clinical outcomes of carbapenem resistance. J Infect Chemother 27:729\u2013735. https:\/\/doi.org\/10.1016\/j.jiac.2020.12.024","journal-title":"J Infect Chemother"},{"key":"7518_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3855\/jidc.4248","volume":"8","author":"A Kumar","year":"2014","unstructured":"Kumar A, Randhawa VS, Nirupam N, Rai Y, Saili A (2014) Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India. J Infect Dev Ctries 8:1049\u20131054. https:\/\/doi.org\/10.3855\/jidc.4248","journal-title":"J Infect Dev Ctries"},{"key":"7518_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10036-5","volume":"24","author":"X He","year":"2024","unstructured":"He X, Tang J, He S, Huang X (2024) Analysis of risk factors and different treatments for infections caused by carbapenem-resistant Acinetobacter baumannii in Shaanxi, China. BMC Infect Dis 24:1130. https:\/\/doi.org\/10.1186\/s12879-024-10036-5","journal-title":"BMC Infect Dis"},{"key":"7518_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-022-00536-0","volume":"21","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zhang X, Wang Y, Tao Y, Shao X, Li Y, Li W (2022) Insight into carbapenem resistance and virulence of Acinetobacter baumannii from a children\u2019s medical centre in eastern China. Ann Clin Microbiol Antimicrob 21:47. https:\/\/doi.org\/10.1186\/s12941-022-00536-0","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"7518_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/1469-0691.12363","volume":"20","author":"EV Lemos","year":"2014","unstructured":"Lemos EV, De La Hoz FP, Einarson TR, McGhan WF, Quevedo E, Casta\u00f1eda C, Kawai K (2014) Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect 20:416\u2013423. https:\/\/doi.org\/10.1111\/1469-0691.12363","journal-title":"Clin Microbiol Infect"},{"key":"7518_CR25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/s12879-018-3511-0","volume":"18","author":"Y Chen","year":"2018","unstructured":"Chen Y, Ai L, Guo P, Huang H, Wu Z, Liang X, Liao K (2018) Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from pediatric intensive care unit in a Chinese tertiary hospital. BMC Infect Dis 18:614. https:\/\/doi.org\/10.1186\/s12879-018-3511-0","journal-title":"BMC Infect Dis"},{"key":"7518_CR26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10096-020-04069-2","volume":"40","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Yang J, Chen Y et al (2021) Microbiological profiles and antimicrobial resistance patterns of pediatric bloodstream pathogens in China, 2016\u20132018. Eur J Clin Microbiol Infect Dis 40:739\u2013749. https:\/\/doi.org\/10.1007\/s10096-020-04069-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"7518_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE et al (2002) Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791\u2013797. https:\/\/doi.org\/10.7326\/0003-4819-137-10-200211190-00007","journal-title":"Ann Intern Med"},{"key":"7518_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07267-9","volume":"22","author":"SJ Mun","year":"2022","unstructured":"Mun SJ, Kim S-H, Kim H-T, Moon C, Wi YM (2022) The epidemiology of bloodstream infection contributing to mortality: the difference between community-acquired, healthcare-associated, and hospital-acquired infections. BMC Infect Dis 22:336. https:\/\/doi.org\/10.1186\/s12879-022-07267-9","journal-title":"BMC Infect Dis"},{"key":"7518_CR29","unstructured":"Centers for Disease Control and Prevention (2026) National Healthcare Safety Network (NHSN) Patient Safety Component Manual. Centers for Disease Control and Prevention, Atlanta, GA. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pscmanual_current.pdf. Accessed 23 Aug 2026"},{"key":"7518_CR30","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2026) Breakpoint tables for interpretation of MICs and zone diameters: document archive. EUCAST, V\u00e4xj\u00f6, Sweden. https:\/\/www.eucast.org\/bacteria\/document-archive\/. Accessed 20 Aug 2026"},{"key":"7518_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.20471\/acc.2022.61.01.06","volume":"61","author":"E \u00c7al\u0131\u015fkan","year":"2022","unstructured":"\u00c7al\u0131\u015fkan E, \u0130nce N, Akar N, \u00d6zt\u00fcrk CE (2022) Investigation of tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii isolates by disc diffusion, agar gradient and broth microdilution tests. Acta Clin Croat 61:46\u201351. https:\/\/doi.org\/10.20471\/acc.2022.61.01.06","journal-title":"Acta Clin Croat"},{"key":"7518_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jmii.2023.11.001","volume":"57","author":"JW Suh","year":"2024","unstructured":"Suh JW, Park SM, Ju YK, Yang KS, Kim JY, Kim SB, Sohn JW, Yoon YK (2024) Clinical and molecular predictors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: a retrospective cohort study. J Microbiol Immunol Infect 57:148\u2013155. https:\/\/doi.org\/10.1016\/j.jmii.2023.11.001","journal-title":"J Microbiol Immunol Infect"},{"key":"7518_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1089\/mdr.2019.0232","volume":"27","author":"X Wang","year":"2021","unstructured":"Wang X, Du Z, Huang W, Zhang X, Zhou Y (2021) Outbreak of multidrug-resistant Acinetobacter baumannii ST208 producing OXA-23-like carbapenemase in a children\u2019s hospital in Shanghai, China. Microb Drug Resist 27:816\u2013822. https:\/\/doi.org\/10.1089\/mdr.2019.0232","journal-title":"Microb Drug Resist"},{"key":"7518_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014937","volume":"98","author":"H Zhou","year":"2019","unstructured":"Zhou H, Yao Y, Zhu B, Ren D, Yang Q, Fu Y, Yu Y, Zhou J (2019) Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: a retrospective study from a Chinese hospital. Medicine (Baltimore) 98:e14937. https:\/\/doi.org\/10.1097\/MD.0000000000014937","journal-title":"Medicine (Baltimore)"},{"key":"7518_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345. https:\/\/doi.org\/10.1086\/599376","journal-title":"Clin Infect Dis"},{"key":"7518_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jac\/dkae387","volume":"80","author":"G Avcu","year":"2025","unstructured":"Avcu G, Erci E, Bilen NM, Ersayoglu I, Ozek G, Celtik U, Terek D, Cilli F, Bal ZS (2025) Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital. J Antimicrob Chemother 80:147\u2013153. https:\/\/doi.org\/10.1093\/jac\/dkae387","journal-title":"J Antimicrob Chemother"},{"key":"7518_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/0885066616677710","volume":"33","author":"Y Lee","year":"2018","unstructured":"Lee Y, Lee Y-T, Wang Y-C et al (2018) Risk of mortality of catheter-related bloodstream infections caused by Acinetobacter species: is early removal of the catheters associated with a better survival outcome? J Intensive Care Med 33:361\u2013369. https:\/\/doi.org\/10.1177\/0885066616677710","journal-title":"J Intensive Care Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07518-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07518-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07518-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:37:24Z","timestamp":1792453044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07518-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7518"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07518-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"28 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ege University Medical Research Ethics Committee (Decision No: 25-10\u00a0T\/18; Date: October 2, 2025). The study was conducted in accordance with the Declaration of Helsinki and institutional regulations governing retrospective human research.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the parents or legal guardians of all participants.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript does not contain any identifiable individual person\u2019s data, images or videos.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"863"}}